BridgeMD
Prevention study for Lung Cancer Screening Program
Official title Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases.
ClinicalTrials.gov ID: NCT06626178
What this study is testing
- What it's testing
- The study is an interventional pilot study. The study is designed to be monocentric and it presents additional procedues.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- High-risk screening people
- Age \>= 50 years old
- Active smokers
- Former smokers (from no more than 15 years)
- Pack/year \>20
You likely can't join if
- Previous or concurrent neoplastic disease, excluding skin cancers
- Cognitive or other problems that could hinder the collection of informed consent
- Severe pulmonary or extra pulmonary disease
- Previous low-dose computed tomography (CT) scan in the past 12 months Previous high-risk positive screening people Inclusion Criteria:
- people enrolled in previous lung cancer screening with the presence of lung nodules \>4 mm and candidate to additional computed tomography (CT)
- Signed informed consent Exclusion Criteria: \- None Previous high-risk negative screening people Inclusion Criteria:
See the full eligibility criteria
- High-risk screening people
- Age \>= 50 years old
- Active smokers
- Former smokers (from no more than 15 years)
- Pack/year \>20
- Risk-prediction model from Prostate, Lung, Colorectal, and Ovarian study (PLCOm2012) \>1.2%
- Provision and signature of informed consent
- Previous or concurrent neoplastic disease, excluding skin cancers
- Cognitive or other problems that could hinder the collection of informed consent
- Severe pulmonary or extra pulmonary disease
- Previous low-dose computed tomography (CT) scan in the past 12 months Previous high-risk positive screening people Inclusion Criteria:
- people enrolled in previous lung cancer screening with the presence of lung nodules \>4 mm and candidate to additional computed tomography (CT)
- Signed informed consent Exclusion Criteria: \- None Previous high-risk negative screening people Inclusion Criteria:
- people enrolled in previous lung cancer screening in this Institute with negative computed tomography (CT)
- Signed informed consent Exclusion Criteria: \- None Lung Cancer patients Inclusion Criteria:
- Patients with diagnosis or suspicious diagnosis of lung cancer candidate to surgical treatment or already submitted to it
- Patients with diagnosis of lung cancer treated with surgical resection
- Signed informed consent Exclusion Criteria:
- computed tomography (CT) scans not available at San Raffaele Hospital
- Previous neoadjuvant treatment
The study team makes the final eligibility decision.
Where it's taking place
- Milan, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milan, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.